Phase 2 clinical trial for FGF401 for the treatment of hepatocellular carcinoma
Latest Information Update: 07 Jun 2021
At a glance
- Drugs Roblitinib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 07 Jun 2021 New trial record
Latest Information Update: 07 Jun 2021